Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H3.2 (H3C15) is a replication-dependent core histone protein encoded by an intronless gene (H3C15/HIST2H3A) located in a histone gene cluster on human chromosome 1[1][2][3][8][9]. It is one of four core histones (H2A, H2B, H3, H4) that together form the nucleosome, the basic structural unit of eukaryotic chromatin, with approximately 146 base pairs of DNA wrapped around a histone octamer. Histone H3.2 plays a central role in the organization and compaction of DNA, limiting accessibility to genetic material. The molecule is subject to numerous post-translational modifications that constitute the 'histone code', influencing DNA-related processes such as transcription, DNA repair, replication, and chromosome stability. This particular variant is not a common direct drug target, but global or site-specific modifications of histone H3 are significant in research on gene regulation and diseases associated with epigenetic dysregulation[1][2][3][9].
Not directly drug-targeted; general histone-modifying agents alter histone code to modulate gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H3.2 (H3C15).